BENEFICIAL EFFECTS OF GINKGO BILOBA IN CANCER
BENEFICIAL EFFECTS OF GINKGO BILOBA IN CANCER
批准号:
6225702
负责人:
Vassilios Papadopoulos
金额:
$19.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2002-12-31
关键词:
Conifera angiogenesis antineoplastics apoptosis athymic mouse breast neoplasms cell cycle cell growth regulation cell proliferation colon neoplasms drug screening /evaluation enzyme linked immunosorbent assay gene expression glioma liver neoplasms medicinal plants microarray technology neoplasm /cancer therapy neoplastic growth nonhuman therapy evaluation northern blottings plant extracts prostate neoplasms radioimmunoassay
中文摘要
描述(申请人摘要):虽然我们对癌症的了解
在戏剧性的进步中,它仍然是导致死亡的主要原因,在
美国,仅次于心脏病。世界范围内死亡人数的增加
从恶性肿瘤中脱颖而出,再加上所有“灵丹妙药”的失败
为预防和/或治愈这些疾病而开发的产品给我们带来了回顾
草药。银杏是世界上最古老的树木和提取物之一。
从它的叶子中被用于传统医学已有数百年
好几年了。在过去的十年里,我们的研究重点是了解
外周型苯二氮卓类受体(PBR)的功能
参与细胞内胆固醇区域化的蛋白质。PBR
侵袭性人乳腺癌细胞的表达显著增加
其中它的表达与细胞增殖增加和
细胞的侵袭性表型。在初步研究中,我们观察到
银杏叶标准化提取物(EGb761)抑制PBR表达
和侵袭性人乳腺癌细胞株MDA-231的细胞增殖,
但不是在非侵袭性细胞系中。使用我们发现的基因表达阵列
EGb 761治疗调节了特定基因产物的表达,
包括癌基因、细胞周期调节因子、细胞凋亡相关产品、
转录因子和生长因子参与多种途径
调节细胞增殖。这些体外数据在体内得到了验证
银杏叶提取物761显著抑制小鼠的生长和PBR
丙二醛-231细胞移植瘤在裸鼠体内的表达综合来看,这些数据
提示银杏叶提取物761可能具有一定的细胞抑制作用。我们的假设是
银杏叶提取物761的细胞抑制作用并不局限于MDA-231细胞,而是
适用于其他致癌肿瘤细胞。我们的第一个具体目标是
通过检查EGb 761对其他攻击性疾病的影响来验证这些发现
乳腺癌细胞株。银杏叶提取物761对细胞增殖的影响
细胞凋亡、细胞周期和基因表达将在体外进行研究。它的影响
原发肿瘤大小、转移与肿瘤血管形成的关系
Area将在体内研究裸鼠细胞异种移植模型。考虑
PBR在胶质瘤、肝癌、结肠癌和其他癌症中也有过表达。
前列腺癌,我们的第二个目标是研究银杏叶提取物对前列腺癌的影响。
调节体外和体内的增殖和生长速度,
分别为胶质瘤、肝癌、结肠癌和前列腺癌细胞。这些
实验应该证明,银杏叶提取物761是否可以用于预防和/或
稳定癌症的进展。
英文摘要
DESCRIPTION (APPLICANT'S ABSTRACT): Although our understanding of cancer has
dramatically progressed, it still remains the leading cause of death, in the
United States, after heart disease. The worldwide increased number of deaths
from malignant tumors together with the failure of all "magic bullets"
developed to prevent and/or cure these diseases brought us to look back at
medicinal herbs. Ginkgo biloba is one of the most ancient trees and extracts
from its leaves have been used in traditional medicine for several hundred
years. Our research for the last decade has focused on understanding the
function of the peripheral-type benzodiazepine receptor (PBR), an ubiquitous
protein involved in intracellular cholesterol compartmentalization. PBR
expression is dramatically increased in aggressive human breast cancer cells
where its expression correlates with the increased cell proliferation and the
aggressive phenotype of the cells. In preliminary studies we observed that the
standardized extract o Ginkgo biloba leaves (EGB 761) inhibited PBR expression
and cell proliferation in the aggressive human breast tumor cell line MDA-23 1,
but not in a non-aggressive cell line. Using a gene expression array we found
that EGB 761 treatment regulated the expression of specific gene products,
including oncogenes, cell cycle regulators, apoptosis-related products,
transcription factors, and growth factors, involved in various pathways
regulating cell proliferation. These in vitro data were validated in an in vivo
model where treatment with EGB 761 significantly inhibited the growth and PBR
expression of MDA-231 cell xenografts in nude mice. Taken together, these data
suggest that EGB 761 may exert cytostatic properties. It is our hypothesis that
the cytostatic effect of EGB 761 is not confined to the MDA-231 cells but
applies to other carcinogenic tumor cells. Our first specific aim is to
validate these findings by examining the effect of EGB 761 on other aggressive
breast cancer cell lines. The effect of EGB 761 on cell proliferation,
apoptosis, cell cycle and gene expression will be studied in vitro. Its effect
on primary tumor size, presence of metastases and vascularization in the tumor
area will be studied in vivo in a cell xenograft nude mice model. Considering
that PBR is also overexpressed in cancers such as gliomas, hepatomas, colon and
prostatic carcinomas, our second aim is to examine the effects of EGB 761 on
regulating the in vitro and in vivo proliferation and growth rates,
respectively, of glioma, hepatoma, colon and prostatic carcinoma cells. These
experiments should demonstrate if EGB 761 could be used to prevent and/or
stabilize the progression of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The XXVth North American Testis Workshop, Lifelong Cell-Cell Interactions in the Testis: A Driver for Male Fertility
-
批准号:9757545
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2019
-
负责人:Vassilios Papadopoulos
-
依托单位:
FERROUS-MEDIATED DHEA IN ALZHEIMER'S DISEASE
-
批准号:7608459
-
项目类别:
-
资助金额:$1.76万
-
财政年份:2007
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7409634
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7515046
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7176488
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7626376
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7100943
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:6966407
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Fetal Origin of Male Reproductive Disorders
-
批准号:7232097
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
DHEA-AD
-
批准号:7376165
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2005
-
负责人:Vassilios Papadopoulos
-
依托单位:
Plasma Diagnostic for Alzheimer's Disease Pathology
-
批准号:6788510
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2004
-
负责人:Vassilios Papadopoulos
-
依托单位:
BENEFICIAL EFFECTS OF GINKGO BILOBA IN CANCER
-
批准号:6488859
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2001
-
负责人:Vassilios Papadopoulos
-
依托单位:
PERIPHERAL BENZODIAZEPINE RECEPTOR IN BREAST CANCER
-
批准号:2821763
-
项目类别:
-
资助金额:$11.39万
-
财政年份:1999
-
负责人:Vassilios Papadopoulos
-
依托单位:
ACUTE HORMONAL REGULATION OF STEROIDOGENESIS
-
批准号:6138847
-
项目类别:
-
资助金额:$24.78万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
ACUTE HORMONAL REGULATION OF STEROIDOGENESIS
-
批准号:2727374
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
Acute Hormonal Regulation of Steroidogenesis
-
批准号:7503990
-
项目类别:
-
资助金额:$20.32万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
Acute Hormonal Regulation of Steriodogenesis
-
批准号:7069637
-
项目类别:
-
资助金额:$30.69万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
Acute Hormonal Regulation of Steriodogenesis
-
批准号:6923748
-
项目类别:
-
资助金额:$31.43万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
ACUTE HORMONAL REGULATION OF STEROIDOGENESIS
-
批准号:6627384
-
项目类别:
-
资助金额:$27.03万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
ACUTE HORMONAL REGULATION OF STEROIDOGENESIS
-
批准号:6343220
-
项目类别:
-
资助金额:$25.48万
-
财政年份:1998
-
负责人:Vassilios Papadopoulos
-
依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位: